✦ LIBER ✦

Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin

✍ Scribed by Yoshinori Inagaki; Wei Tang; Masatoshi Makuuchi; Kiyoshi Hasegawa; Yasuhiko Sugawara; Norihiro Kokudo

Book ID: 111239386
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 420 KB
Volume: 31
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2010.02348.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma des-γ-carboxyprothrombin in the e

Plasma des-γ-carboxyprothrombin in the early stage of hepatocellular carcinoma

✍ Sun-Lung Tsai; Guan-Tarn Huang; Pei-Ming Yang; Jin-Chuan Sheu; Juei-Low Sung; Pr 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

## DING-SHINN CHEN To evaluate the role of plasma des-y-carboxyprothrombin in the early diagnosis of hepatocellular carcinoma, we simultaneously studied both des-y-carboxyprothrombin activities by staphylocoagulase method and des-y-carboxyprothrombin antigen levels by enzyme immunoassay in 39 pati

The value of a new marker, des-γ-carboxy

The value of a new marker, des-γ-carboxyprothrombin (DCP) in the diagnosis of primary hepatocellular carcinoma (PHC)

✍ Kavallierou, L.; Tsiodra, P.; Efstratopoulos, A.; Meikopoulos, M.; Pittaros, Ch. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Distribution of the heterogeneity of des

Distribution of the heterogeneity of des-γ-carboxyprothrombin in patients with hepatocellular carcinoma

✍ SOICHIRO UEHARA; KATSUHIRO GOTOH; HIROSHI HANDA; HIROSHI TOMITA; MITIKO SENSHUU 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Evaluation of the effect of sorafenib us

Evaluation of the effect of sorafenib using serum NX-des-γ-carboxyprothrombin in patients with hepatocellular carcinoma

✍ Miyahara, Koji; Nouso, Kazuhiro; Morimoto, Yuki; Tomoda, Takeshi; Kobayashi, Say 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB